NRG-HN004

Head/Neck - NRG-HN004

NRG-HN004

Objective

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin

Principal Investigator(s)
Vanessa Dickey, MD
Zachary Zumsteg, MD

Clinical Trial Categories

  • Cedars-Sinai Clinical Trials